Literature DB >> 8318354

Neuropeptides as growth and differentiation factors in general and VIP in particular.

I Gozes1, D E Brenneman.   

Abstract

During the course of neurodevelopment a large population of neurons die normally (Berg, 1982; Oppenheim et al., 1989). Are neuropeptides involved in the regulation of neuronal survival, maturation, and maintenance? The peptides are an ever growing family of neuroactive agents and this review shall emphasize VIP (vasoactive intestinal peptide [Said and Mutt, 1970; Gozes and Brenneman, 1989]), which has been shown to be involved in maturation, growth, and maintenance of neurons (Brenneman et al., 1985a, 1987, 1988, 1990, 1990b; Brenneman and Eiden, 1986; Brenneman and Nelson, 1986). Comparative actions of other neuropeptides will also be discussed.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8318354     DOI： 10.1007/BF02736685

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN： 0895-8696            Impact factor:   3.444


  70 in total

1.  An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.

Authors:  I Gozes; S K McCune; L Jacobson; D Warren; T W Moody; M Fridkin; D E Brenneman
Journal:  J Pharmacol Exp Ther       Date:  1991-06       Impact factor: 4.030

2.  Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts.

Authors:  D W Pincus; E M DiCicco-Bloom; I B Black
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

3.  Vasoactive intestinal peptide gene expression from embryos to aging rats.

Authors:  I Gozes; P Schächter; Y Shani; E Giladi
Journal:  Neuroendocrinology       Date:  1988-01       Impact factor: 4.914

Review 4.  Biosynthesis and regulation of expression. The vasoactive intestinal peptide gene.

Authors:  I Gozes
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

5.  Responses to cell contacts between growth cones, neurites and ganglionic non-neuronal cells.

Authors:  N K Wessells; P C Letourneau; R P Nuttall; M Ludueña-Anderson; J M Geiduschek
Journal:  J Neurocytol       Date:  1980-10

6.  Hypothalamic vasoactive intestinal peptide messenger ribonucleic acid is increased in lactating rats.

Authors:  I Gozes; Y Shani
Journal:  Endocrinology       Date:  1986-12       Impact factor: 4.736

7.  Developmental and neurochemical specificity of neuronal deficits produced by electrical impulse blockade in dissociated spinal cord cultures.

Authors:  D E Brenneman; E A Neale; W H Habig; L M Bowers; P G Nelson
Journal:  Brain Res       Date:  1983-07       Impact factor: 3.252

8.  Motoneurone survival is induced by immature astrocytes from developing avian spinal cord.

Authors:  K L Eagleson; T R Raju; M R Bennett
Journal:  Brain Res       Date:  1985-01       Impact factor: 3.252

9.  Interaction between trophic action and electrical activity in spinal cord cultures.

Authors:  D E Brenneman; S Fitzgerald; P G Nelson
Journal:  Brain Res       Date:  1984-08       Impact factor: 3.252

10.  Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide.

Authors:  D E Brenneman; E A Neale; G A Foster; S W d'Autremont; G L Westbrook
Journal:  J Cell Biol       Date:  1987-06       Impact factor: 10.539
View more
  11 in total

1.  VIP, from gene to behavior and back: summarizing my 25 years of research.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

Review 2.  A VIP hybrid antagonist: from developmental neurobiology to clinical applications.

Authors:  I Gozes; M Fridkin; D E Brenneman
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

3.  Protection against developmental deficiencies by a lipophilic VIP analogue.

Authors:  I Gozes; M Bachar; A Bardea; A Davidson; S Rubinraut; M Fridkin
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

4.  Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.

Authors:  I Gozes; O Perl; E Giladi; A Davidson; O Ashur-Fabian; S Rubinraut; M Fridkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 5.  Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

Review 6.  VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment.

Authors:  J M Muller; V Lelievre; L Becq-Giraudon; A C Meunier
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

7.  Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene.

Authors:  I Gozes; J Glowa; D E Brenneman; S K McCune; E Lee; H Westphal
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

8.  Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro.

Authors:  Christine Dufes; Céline Alleaume; Alicia Montoni; Jean-Christophe Olivier; Jean-Marc Muller
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

9.  Distribution and origin of the peripheral innervation of rat cervical esophagus.

Authors:  R Uddman; T Grunditz; A Luts; H Desai; G Fernström; F Sundler
Journal:  Dysphagia       Date:  1995       Impact factor: 3.438

10.  Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.

Authors:  I Gozes; A Bardea; A Reshef; R Zamostiano; S Zhukovsky; S Rubinraut; M Fridkin; D E Brenneman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.